NaughtyPines

THE WEEK AHEAD: TSLA EARNINGS, EEM

NASDAQ:TSLA   Tesla
Although AAPL and GILD announce earnings next week, the only earnings announcement that interests me from a premium selling standpoint is TSLA, with a background implied volatility of over 65%.

The 73% probability of profit May 11th 255/330 short strangle is paying 5.83 at the mid (off hours quotes) with its defined risk counterpart, the 68% probability of profit May 11th 250/255/330/335 iron condor paying 1.06, which is less than I'd like to see out of a 5-wide.

On the exchange-traded fund front, most of the most liquid funds are sub-35% implied volatility, which generally makes for less than compelling premium selling plays. For what it's worth, however, the top five ranked by implied volatility are: XOP (30.4%), OIH (30.2%), EWZ (27.4%), GDXJ (25.5%), and FXI (23.1%). I'm already in XOP and GDX plays, so I might consider having another go at "the Brazilian" in the June cycle -- the June 15th 39/47 short strangle (18 delta) is paying .77. Naturally, more aggressive delta strikes pay more, and it may be amenable to a short straddle/iron fly, depending on your account size, risk appetite, and patience for managing an underlying that seems to whip all over the place on occasion ... .

Alternatively, I might go with another net credit double diagonal due to setup flexibility over a static one-off play, this time in the fairly broad market EEM, which has been closely tracking FXI of late, but is of greater liquidity: the June/Sept 44/47/47.5/50.5 double net credit diagonal is .26 at the mid for a three-wide, and I'd probably look to bail on it at 20% the width of the 3.00 wings ... .

I'll also look at bullish directional shots in IYR, XLI, XHB, and/or XLP, which appear to be the weakest of the sectors currently. Pricing those out in non-New York hours tends to be non-productive since the deep-in-the-money back months show wide bid/ask in off hours, so it's tough to tell how much you're going to have to commit buying power wise to play ... .
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.